BB Biotech Update March 2021

March was another volatile month for the healthcare sector in general and the biotech sector in particular. We are still seeing steady progress with the SARS-CoV-2 vaccine rollouts and in the US more than 30% of the population has received one or more doses. BB Biotech´s portfolio company Moderna is still one of the leaders in the vaccines field with the US alone administering more than 67 million doses of the mRNA-1273 vaccine to date. On March 29 Moderna announced that another 100 million doses have shipped to the US government.